Next Article 
Molecular and Cellular Biology, August 2003, p. 5113-5121, Vol. 23, No. 15
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.15.5113-5121.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
MDM2 Promotes Ubiquitination and Degradation of MDMX
Yu Pan and Jiandong Chen*
Molecular Oncology Program, H. Lee Moffitt Comprehensive Cancer Center and Research Institute, Tampa, Florida 33612
Received 21 November 2002/
Returned for modification 6 January 2003/
Accepted 7 May 2003
The p53 tumor suppressor is regulated by MDM2-mediated ubiquitination and degradation. Mitogenic signals activate p53 by induction of ARF expression, which inhibits p53 ubiquitination by MDM2. Recent studies showed that the MDM2 homolog MDMX is also an important regulator of p53. We present evidence that MDM2 promotes MDMX ubiquitination and degradation by the proteasomes. This effect is stimulated by ARF and correlates with the ability of ARF to bind MDM2. Promotion of MDM2-mediated MDMX ubiquitination requires the N-terminal domain of ARF, which normally inhibits MDM2 ubiquitination of p53. An intact RING domain of MDM2 is also required, both to interact with MDMX and to provide E3 ligase function. Increase of MDM2 and ARF levels by DNA damage, recombinant ARF adenovirus infection, or inducible MDM2 expression leads to proteasome-mediated down-regulation of MDMX levels. Therefore, MDMX and MDM2 are coordinately regulated by stress signals. The ARF tumor suppressor differentially regulates the ability of MDM2 to promote p53 and MDMX ubiquitination and activates p53 by targeting both members of the MDM2 family.
* Corresponding author. Mailing address: H. Lee Moffitt Cancer Center, MRC3057A, 12902 Magnolia Dr., Tampa, FL 33612. Phone: (813) 903-6822. Fax: (813) 903-6817. E-mail:
jchen{at}moffitt.usf.edu.
Molecular and Cellular Biology, August 2003, p. 5113-5121, Vol. 23, No. 15
0022-538X/03/$08.00+0 DOI: 10.1128/MCB.23.15.5113-5121.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Pazgier, M., Liu, M., Zou, G., Yuan, W., Li, C., Li, C., Li, J., Monbo, J., Zella, D., Tarasov, S. G., Lu, W.
(2009). Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX. Proc. Natl. Acad. Sci. USA
106: 4665-4670
[Abstract]
[Full Text]
-
Zuckerman, V., Lenos, K., Popowicz, G. M., Silberman, I., Grossman, T., Marine, J.-C., Holak, T. A., Jochemsen, A. G., Haupt, Y.
(2009). c-Abl Phosphorylates Hdmx and Regulates Its Interaction with p53. J. Biol. Chem.
284: 4031-4039
[Abstract]
[Full Text]
-
Wade, M., Wahl, G. M.
(2009). Targeting Mdm2 and Mdmx in Cancer Therapy: Better Living through Medicinal Chemistry?. Mol Cancer Res
7: 1-11
[Abstract]
[Full Text]
-
Makki, M. S., Heinzel, T., Englert, C.
(2008). TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels. Nucleic Acids Res
36: 4067-4078
[Abstract]
[Full Text]
-
Maguire, M., Nield, P. C., Devling, T., Jenkins, R. E., Park, B. K., Polanski, R., Vlatkovic, N., Boyd, M. T.
(2008). MDM2 Regulates Dihydrofolate Reductase Activity through Monoubiquitination. Cancer Res.
68: 3232-3242
[Abstract]
[Full Text]
-
Gilkes, D. M., Pan, Y., Coppola, D., Yeatman, T., Reuther, G. W., Chen, J.
(2008). Regulation of MDMX Expression by Mitogenic Signaling. Mol. Cell. Biol.
28: 1999-2010
[Abstract]
[Full Text]
-
Hu, B., Gilkes, D. M., Chen, J.
(2007). Efficient p53 Activation and Apoptosis by Simultaneous Disruption of Binding to MDM2 and MDMX. Cancer Res.
67: 8810-8817
[Abstract]
[Full Text]
-
Wang, Y. V., Wade, M., Wong, E., Li, Y.-C., Rodewald, L. W., Wahl, G. M.
(2007). Quantitative analyses reveal the importance of regulated Hdmx degradation for P53 activation. Proc. Natl. Acad. Sci. USA
104: 12365-12370
[Abstract]
[Full Text]
-
Kawai, H., Lopez-Pajares, V., Kim, M. M., Wiederschain, D., Yuan, Z.-M.
(2007). RING Domain-Mediated Interaction Is a Requirement for MDM2's E3 Ligase Activity. Cancer Res.
67: 6026-6030
[Abstract]
[Full Text]
-
Giono, L. E., Manfredi, J. J.
(2007). Mdm2 Is Required for Inhibition of Cdk2 Activity by p21, Thereby Contributing to p53-Dependent Cell Cycle Arrest. Mol. Cell. Biol.
27: 4166-4178
[Abstract]
[Full Text]
-
Kannemeier, C., Liao, R., Sun, P.
(2007). The RING Finger Domain of MDM2 Is Essential for MDM2-mediated TGF-beta Resistance. Mol. Biol. Cell
18: 2367-2377
[Abstract]
[Full Text]
-
Marine, J.-C. W., Dyer, M. A., Jochemsen, A. G.
(2007). MDMX: from bench to bedside. J. Cell Sci.
120: 371-378
[Abstract]
[Full Text]
-
Hu, B., Gilkes, D. M., Farooqi, B., Sebti, S. M., Chen, J.
(2006). MDMX Overexpression Prevents p53 Activation by the MDM2 Inhibitor Nutlin. J. Biol. Chem.
281: 33030-33035
[Abstract]
[Full Text]
-
Pereg, Y., Lam, S., Teunisse, A., Biton, S., Meulmeester, E., Mittelman, L., Buscemi, G., Okamoto, K., Taya, Y., Shiloh, Y., Jochemsen, A. G.
(2006). Differential Roles of ATM- and Chk2-Mediated Phosphorylations of Hdmx in Response to DNA Damage.. Mol. Cell. Biol.
26: 6819-6831
[Abstract]
[Full Text]
-
Datta, A., Bellon, M., Sinha-Datta, U., Bazarbachi, A., Lepelletier, Y., Canioni, D., Waldmann, T. A., Hermine, O., Nicot, C.
(2006). Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood
108: 1021-1029
[Abstract]
[Full Text]
-
Xiong, S., Van Pelt, C. S., Elizondo-Fraire, A. C., Liu, G., Lozano, G.
(2006). Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development. Proc. Natl. Acad. Sci. USA
103: 3226-3231
[Abstract]
[Full Text]
-
Okamoto, K., Kashima, K., Pereg, Y., Ishida, M., Yamazaki, S., Nota, A., Teunisse, A., Migliorini, D., Kitabayashi, I., Marine, J.-C., Prives, C., Shiloh, Y., Jochemsen, A. G., Taya, Y.
(2005). DNA Damage-Induced Phosphorylation of MdmX at Serine 367 Activates p53 by Targeting MdmX for Mdm2-Dependent Degradation. Mol. Cell. Biol.
25: 9608-9620
[Abstract]
[Full Text]
-
Chen, L., Li, C., Pan, Y., Chen, J.
(2005). Regulation of p53-MDMX Interaction by Casein Kinase 1 Alpha. Mol. Cell. Biol.
25: 6509-6520
[Abstract]
[Full Text]
-
Pereg, Y., Shkedy, D., de Graaf, P., Meulmeester, E., Edelson-Averbukh, M., Salek, M., Biton, S., Teunisse, A. F. A. S., Lehmann, W. D., Jochemsen, A. G., Shiloh, Y.
(2005). Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage. Proc. Natl. Acad. Sci. USA
102: 5056-5061
[Abstract]
[Full Text]
-
Brady, M., Vlatkovic, N., Boyd, M. T.
(2005). Regulation of p53 and MDM2 Activity by MTBP. Mol. Cell. Biol.
25: 545-553
[Abstract]
[Full Text]
-
Li, Z., Day, C.-P., Yang, J.-Y., Tsai, W.-B., Lozano, G., Shih, H.-M., Hung, M.-C.
(2004). Adenoviral E1A Targets Mdm4 to Stabilize Tumor Suppressor p53. Cancer Res.
64: 9080-9085
[Abstract]
[Full Text]
-
Jin, Y., Zeng, S. X., Lee, H., Lu, H.
(2004). MDM2 Mediates p300/CREB-binding Protein-associated Factor Ubiquitination and Degradation. J. Biol. Chem.
279: 20035-20043
[Abstract]
[Full Text]
-
Mancini, F., Gentiletti, F., D'Angelo, M., Giglio, S., Nanni, S., D'Angelo, C., Farsetti, A., Citro, G., Sacchi, A., Pontecorvi, A., Moretti, F.
(2004). MDM4 (MDMX) Overexpression Enhances Stabilization of Stress-induced p53 and Promotes Apoptosis. J. Biol. Chem.
279: 8169-8180
[Abstract]
[Full Text]
-
Moll, U. M., Petrenko, O.
(2003). The MDM2-p53 Interaction. Mol Cancer Res
1: 1001-1008
[Abstract]
[Full Text]